Want to find your lens? Five questions, no jargon — they tell you which of four reads fits how you already think.
A wonderful business — priced for growth it hasn't delivered.
A great company, but no margin of safety at this price. Worth watching, not worth buying here.
The five checks
2 good · 1 caution · 2 warning
- WarningOvervaluedFair value ~$109 vs $170 — trading 36% above what the math supports.
- WarningPrice assumes a big accelerationYou'd need ~10%/yr free-cash-flow growth to justify today's price; it has done 3.2%/yr lately.
- GoodRevenue still growingUp 3.3% last year — demand isn't the problem.
- GoodCash flow compoundingFree cash flow up ~3.2%/yr — the engine is growing.
- CautionManageable net debtNet debt of $24B — about 1.6× annual free cash flow. Normal for a mature company.
Price against fair value
What today's price assumes
Hold the price fixed and work backwards: how fast would free cash flow have to grow for $170 to make sense?
Price assumes a big acceleration.
How fair value is calculated
No analyst forecasts, no black box, no AI. Six lines from the filing to the answer.
- Free cash flow, FY26Operating cash flow less capital spending, from the annual report$15B
- Ten years of it, growing 5% a year, each counted 9% lessThe same growth and discount for every company$124B
- Everything after year tenGrowing 2.5% a year, counted the same way+ $164B
- The business, in today's money$288B
- Subtract net debtBorrowings and finance leases less cash and securities− $24B
- Divide by the shares on file÷ 2.4225B
Fair value per share$109
If our assumptions are wrong
Fair value per share under a faster or slower decade, and a gentler or harsher discount. The corners are where the $79 to $156 range comes from.
| 3% growth | 5% growth | 7% growth | |
|---|---|---|---|
| 8% discount | $111 | $132 | $156 |
| 9% discount | $92 | $109 | $129 |
| 10% discount | $79 | $93 | $109 |
The blue cell is the published method. Every cell sits below today’s price.
Free cash flow, ten years
$ billions · Form 10-K
What the math is really telling you. Watch whether cash flow is compounding — that, more than any single year, is what a value read hangs on.
How this was built. Every figure is computed from The Procter & Gamble Company's SEC filings — no estimates, no AI. Two-stage DCF: 9% discount rate, 5% free-cash-flow growth for 10 years, 2.5% terminal. Free cash flow is operating cash flow less capital spending. Net cash is cash and marketable securities less borrowings, commercial paper and finance leases; operating leases are disclosed but never counted as debt. Fundamentals are from the FY26 annual report and change only when a new one is filed. Price of $169.80 taken 2026-11-15 (Google Finance, manual entry, 2026-11-13) — it is not live and does not move during the day.
Read Procter & Gamble another way
TickerMath is an educational tool, not investment advice — it computes one model from SEC filings and can be wrong. How we compute this →